Clinical Benefit of Low Molecular Weight Heparin for ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Glycoprotein IIb/IIIa Inhibitor

The efficacy of low molecular weight heparin (LMWH) with low dose unfractionated heparin (UFH) during percutaneous coronary intervention (PCI) with or without glycoprotein (Gp) IIb/IIIa inhibitor compared to UFH with or without Gp IIb/IIIa inhibitor has not been elucidated. Between October 2005 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Jung Sun, Her, Sung-Ho, Baek, Ju Yeal, Park, Mahn-Won, Kim, Hyoung Doo, Jeong, Myung Ho, Ahn, Young keun, Chae, Shung Chull, Hur, Seung Ho, Hong, Taek Jong, Kim, Young Jo, Seong, In Whan, Chae, Jei Keon, Rhew, Jay Young, Chae, In Ho, Cho, Myeong Chan, Bae, Jang Ho, Rha, Seung Woon, Kim, Chong Jim, Choi, Donghoon, Jang, Yang Soo, Yoon, Junghan, Chung, Wook Sung, Cho, Jeong Gwan, Seung, Ki Bae, Park, Seung Jung
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966997/
https://www.ncbi.nlm.nih.gov/pubmed/21060749
http://dx.doi.org/10.3346/jkms.2010.25.11.1601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966997/
https://www.ncbi.nlm.nih.gov/pubmed/21060749
http://dx.doi.org/10.3346/jkms.2010.25.11.1601

Ejemplares similares